Citation

BibTex format

@article{Quammie:2026:10.1136/bmjgast-2025-002194,
author = {Quammie, S and Rashid, A and Munyal, R and Nicholson, ES and Clarke, C and Venkatachalapathy, SV and Crooks, CJ and Aithal, GP and Aravinthan, AD and DEMISTIFI, Consortium},
doi = {10.1136/bmjgast-2025-002194},
journal = {BMJ Open Gastroenterol},
title = {Burden of non-cancer comorbidities and mortality in chronic pancreatitis: a retrospective cohort study.},
url = {http://dx.doi.org/10.1136/bmjgast-2025-002194},
volume = {13},
year = {2026}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - OBJECTIVE: Chronic pancreatitis (CP) is a progressive fibro-inflammatory disease associated with increased comorbidity and mortality. This study aimed to characterise the natural history of CP by assessing comorbidity prevalence and mortality in a CP cohort. METHODS: A retrospective cohort study was performed at Nottingham University Hospitals NHS Trust, including patients diagnosed with CP between 1 January 2006 and 31 December 2014. Participants were followed up until 31 May 2023. Comorbidity prevalence was compared with national data from England in 2022 to calculate standardised prevalence ratios (SPRs). Similarly, standardised mortality ratios (SMRs) were also evaluated. RESULTS: Of the 1003 patients with CP, 678 who resided within the Greater Nottingham area were included in the study cohort. The overall median follow-up was 5.7 years (IQR 1.2-10.6). Compared with the general population, patients with CP had significantly elevated SPRs for heart failure (3.0; 95% CI 2.3 to 3.8), diabetes mellitus (2.4; 95% CI 2.1 to 2.7), ischaemic heart disease (2.4; 95% CI 2.0 to 2.8), atrial fibrillation (1.9; 95% CI 1.5 to 2.3) and cerebrovascular disease (1.4; 95% CI 1.0 to 1.8). The cumulative incidence at 20 years of diabetes mellitus, chronic liver disease and chronic kidney disease was 12%, 11% and 11%, respectively. During follow-up, 495 patients (73%) died, with median survival of 5.7 years (95% CI 4.8 to 6.4). The overall SMR of patients with CP was significantly increased (2.3; 95% CI 2.1 to 2.6; p<0.0001) compared with the general population. Leading causes of death were malignancy (27%), infections (22%) and cardiovascular disease (6.9%). CONCLUSION: CP is associated with increased risk of multiple comorbidities and elevated mortality as compared with the general population. Enhanced surveillance and early intervention strategies may help prevent or delay the onset of these associated conditions.
AU  - Quammie,S
AU  - Rashid,A
AU  - Munyal,R
AU  - Nicholson,ES
AU  - Clarke,C
AU  - Venkatachalapathy,SV
AU  - Crooks,CJ
AU  - Aithal,GP
AU  - Aravinthan,AD
AU  - DEMISTIFI,Consortium
DO  - 10.1136/bmjgast-2025-002194
PY  - 2026///
SN  - 2054-4774
TI  - Burden of non-cancer comorbidities and mortality in chronic pancreatitis: a retrospective cohort study.
T2  - BMJ Open Gastroenterol
UR  - http://dx.doi.org/10.1136/bmjgast-2025-002194
UR  - https://www.ncbi.nlm.nih.gov/pubmed/42167798
VL  - 13
ER  -
Download

Our Section is involved in

Public Engagement
Find out about past and present activities